J & J s Sergey Ilyin Marries Bioinformatics and HTS for Functional Informatics | GenomeWeb

In an effort to bridge the gap between target discovery and target validation, a research team at Johnson & Johnson Pharmaceutical R&D has merged bioinformatics with high-throughput screening to create a new research strategy they’ve dubbed “functional informatics.” Led by Sergey Ilyin, bioinformatics group leader, the Spring House, Pa.-based R&D group found that integrating several technologies that are traditionally isolated in “research silos” was the best approach to functionally characterizing target molecules.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.